Did you know that the UK pays up to £30,000 per QALY (Quality Adjusted Life Year) for drugs used by their patients. In the US, organizations like ICER may evaluate the value of life-saving drugs, and the reimbursements can be even higher. Organizations like ISPOR—The Professional Society for Health Economics and Outcomes Research and Medical Affairs Professional Society (MAPS) do a phenomenal job in sharing best practices to enhance patient outcomes.
At Clinakos Inc., we empower Life Sciences companies with Integrated Patient Data™ solutions to drive and demonstrate exceptional patient outcomes. Interested in learning more? Message us for further details.
